- Organization name
- UDI-DI code
- Reference / catalog number
EUDAMED last updated this device on Mar 1, 2024
B-795027SCNADAL TPHA Microplate Haemagglutination Test is an IVDD-legacy in vitro diagnostic registered in EUDAMED. It is classified as IVDD — General. Manufactured by nal von minden GmbH. Placed on the EU market in Germany. Explore certificates, regulatory status and the EUDAMED record on MD Atlas.
D-795027SC795027D-795027SC
DataMatrix generation currently supports GS1-issued UDIs. HIBCC / ICCBBA / IFA support is coming.
European Medical Device Nomenclature — the EU product classification assigned to this device.
W0105090105SYPHILIS - RT & POC1 warning recorded — scroll inside the panel to see all entries.
Primary placement in Germany; available across 1 country total.
Placed on the market in Germany; per-country availability dates not published.
DE-MF-000013321Sterile
A sterile device is supplied free of viable micro-organisms — flagged so that it is handled, stored and used to preserve that sterile state.
View in glossary →Single-use device
A single-use device is intended to be used on one patient during a single procedure and then discarded — not reprocessed or reused.
View in glossary →Primary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
View in glossary →Basic UDI-DI
The Basic UDI-DI is the main identifier that groups together all device variants of the same model — the regulatory "family" key.
View in glossary →UDI issuing entities
Issuing entities are the organisations the European Commission has designated to assign Unique Device Identifiers under the EU's UDI system.
View in glossary →IVDR risk classes
IVDR risk classes rank in-vitro diagnostic devices from lowest risk (Class A) to highest (Class D), based on the patient and public-health risk of a wrong result.
View in glossary →Primary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
View in glossary →Certificate health across this manufacturer's portfolio.
IX 1034230-2IssuedHX 1034230-1IssuedNotified body
A notified body is an independent organisation, designated by an EU country, that audits manufacturers and certifies higher-risk devices before they can be CE-marked.
View in glossary →Notified body
A notified body is an independent organisation, designated by an EU country, that audits manufacturers and certifies higher-risk devices before they can be CE-marked.
View in glossary →B-nvm-103567S-25YQOn the marketNADAL Strep A TestB-221901N-405UOn the marketNADAL Strep A TestB-222901N-2069On the marketNADAL® Cardiac Combo TestB-nvm-282003SWOn the marketNADAL® Chlamydia Test (CE0197)B-nvm-212007QROn the marketNADAL® COVID-19 Ag TestB-nvm-243103N-25PARXOn the marketNo certificate specifically references this device's Basic UDI-DI.